Application of biclustering of gene expression data and gene set enrichment analysis methods to identify potentially disease causing nanomaterials

Scholarly Works

• Bahl, A.; Halappanavar, S.; Wohlleben, W.; Nymark, P.; Kohonen, P.; Wallin, H.; Vogel, U.; Haase, A. Bioinformatics and machine learning to support nanomaterial grouping. Nanotoxicology 2024, 18, 373–400. doi:10.1080/17435390.2024.2368005
• Patrício, A.; Costa, R. S.; Henriques, R. On the challenges of predicting treatment response in Hodgkin's Lymphoma using transcriptomic data. BMC medical genomics 2023, 16, 170. doi:10.1186/s12920-023-01508-9
• Solorio-Rodriguez, S. A.; Williams, A.; Poulsen, S. S.; Knudsen, K. B.; Jensen, K. A.; Clausen, P. A.; Danielsen, P. H.; Wallin, H.; Vogel, U.; Halappanavar, S. Single-Walled vs. Multi-Walled Carbon Nanotubes: Influence of Physico-Chemical Properties on Toxicogenomics Responses in Mouse Lungs. Nanomaterials (Basel, Switzerland) 2023, 13, 1059. doi:10.3390/nano13061059
• Jagiello, K.; Ciura, K. In vitro to in vivo extrapolation to support the development of the next generation risk assessment (NGRA) strategy for nanomaterials. Nanoscale 2022, 14, 6735–6742. doi:10.1039/d2nr00664b
• Nymark, P.; Sachana, M.; Leite, S. B.; Sund, J.; Krebs, C. E.; Sullivan, K.; Edwards, S. W.; Viviani, L.; Willett, C.; Landesmann, B.; Wittwehr, C. Systematic Organization of COVID-19 Data Supported by the Adverse Outcome Pathway Framework. Frontiers in public health 2021, 9, 638605. doi:10.3389/fpubh.2021.638605
• Halappanavar, S.; Nymark, P.; Krug, H. F.; Clift, M. J. D.; Rothen-Rutishauser, B.; Vogel, U. Non-Animal Strategies for Toxicity Assessment of Nanoscale Materials: Role of Adverse Outcome Pathways in the Selection of Endpoints. Small (Weinheim an der Bergstrasse, Germany) 2021, 17, 2007628. doi:10.1002/smll.202007628
• Halappanavar, S.; van den Brule, S.; Nymark, P.; Gaté, L.; Seidel, C.; Valentino, S.; Zhernovkov, V.; Danielsen, P. H.; De Vizcaya, A.; Wolff, H.; Stöger, T.; Boyadziev, A.; Poulsen, S. S.; Sørli, J. B.; Vogel, U. Adverse outcome pathways as a tool for the design of testing strategies to support the safety assessment of emerging advanced materials at the nanoscale. Particle and fibre toxicology 2020, 17, 16. doi:10.1186/s12989-020-00344-4
• Rahman, L.; Williams, A.; Gelda, K.; Nikota, J. K.; Wu, D.; Vogel, U.; Halappanavar, S. 21st Century Tools for Nanotoxicology: Transcriptomic Biomarker Panel and Precision‐Cut Lung Slice Organ Mimic System for the Assessment of Nanomaterial‐Induced Lung Fibrosis. Small (Weinheim an der Bergstrasse, Germany) 2020, 16, 2000272. doi:10.1002/smll.202000272
• Nymark, P.; Bakker, M.; Dekkers, S.; Franken, R.; Fransman, W.; García-Bilbao, A.; Greco, D.; Gulumian, M.; Hadrup, N.; Halappanavar, S.; Hongisto, V.; Hougaard, K. S.; Jensen, K. A.; Kohonen, P.; Koivisto, A. J.; Dal Maso, M.; Oosterwijk, T.; Poikkimäki, M.; Rodriguez-Llopis, I.; Stierum, R.; Sørli, J. B.; Grafström, R. C. Toward Rigorous Materials Production: New Approach Methodologies Have Extensive Potential to Improve Current Safety Assessment Practices. Small (Weinheim an der Bergstrasse, Germany) 2020, 16, 1904749. doi:10.1002/smll.201904749
• Yauk, C. L.; Cheung, C.; Barton-Maclaren, T. S.; Boucher, S.; Bourdon-Lacombe, J.; Chauhan, V.; Gagne, M.; Gillespie, Z.; Halappanavar, S.; Honeyman, M.; Jones, S. R.; Jones-McLean, E.; Labib, S.; MacAulay, J.; Moore, J.; Paquette, M. A.; Petronella, N.; Semalulu, S.; Slot, A.; Vespa, A.; Woodland, C. L. Toxicogenomic applications in risk assessment at Health Canada. Current Opinion in Toxicology 2019, 18, 34–45. doi:10.1016/j.cotox.2019.02.005
• Karim, M. B.; Kanaya, S.; Altaf-Ul-Amin. Implementation of BiClusO and its comparison with other biclustering algorithms. Applied Network Science 2019, 4, 1–15. doi:10.1007/s41109-019-0180-x
• Gusfield, D. 2019.
• Gusfield, D. Part II. Integer Linear Programming in Computational and Systems Biology; Cambridge University Press, 2019; pp 233–234. doi:10.1017/9781108377737.015
• Gusfield, D. Part I. Integer Linear Programming in Computational and Systems Biology; Cambridge University Press, 2019; pp 1–2. doi:10.1017/9781108377737.002
• Gusfield, D. Biological Networks, Graphs, and High-Density Subgraphs. Integer Linear Programming in Computational and Systems Biology; Cambridge University Press, 2019; pp 15–48. doi:10.1017/9781108377737.004
• Gusfield, D. Introduction. Integer Linear Programming in Computational and Systems Biology; Cambridge University Press, 2019; xi–xviii. doi:10.1017/9781108377737.001
• Gusfield, D. Maximum Likelihood Pedigree Reconstruction. Integer Linear Programming in Computational and Systems Biology; Cambridge University Press, 2019; pp 331–342. doi:10.1017/9781108377737.022
• Gusfield, D. Character Compatibility with Corrupted Data and Generalized Phylogenetic Models. Integer Linear Programming in Computational and Systems Biology; Cambridge University Press, 2019; pp 260–272. doi:10.1017/9781108377737.017
• Gusfield, D. Integer Programming in Molecular Sequence Analysis. Integer Linear Programming in Computational and Systems Biology; Cambridge University Press, 2019; pp 186–204. doi:10.1017/9781108377737.012
• Gusfield, D. What's Next?. Integer Linear Programming in Computational and Systems Biology; Cambridge University Press, 2019; pp 382–384. doi:10.1017/9781108377737.025

Explore citations to this article at